Skip Content
You are currently on the new version of our website. Access the old version .

Pharmaceuticals, Volume 3, Issue 12

2010 December - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Commentary
  • Open Access
1 Citations
9,241 Views
4 Pages

17 December 2010

The recent review of Matthew D. Krasowski on ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’ is a useful foundation of comparative interpretations on our current knowledge about therapeutic drug monitoring. Within the review, the...

  • Article
  • Open Access
72 Citations
13,105 Views
20 Pages

Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity

  • Jose A. Gomez,
  • Joseph Chen,
  • Justine Ngo,
  • Dagmar Hajkova,
  • I-Ju Yeh,
  • Vivian Gama,
  • Masaru Miyagi and
  • Shigemi Matsuyama

15 December 2010

Previously, we developed cell-penetrating penta-peptides (CPP5s). In the present study, VPTLK and KLPVM, two representative CPP5s, were used to characterize the cell-penetration and protein-transduction activities of these small molecules. Various in...

  • Review
  • Open Access
19 Citations
14,126 Views
15 Pages

Pharmacogenetics of SSRIs and Sexual Dysfunction

  • Liana Osis and
  • Jeffrey R. Bishop

15 December 2010

Sexual dysfunction (SD) is a common and disconcerting side effect of selective serotonin reuptake inhibitors (SSRIs) that often influences a patient’s desire to continue long-term antidepressant treatment. Studies specifically assessing changes in se...

  • Review
  • Open Access
25 Citations
10,225 Views
13 Pages

14 December 2010

With the rapidly spreading resistance of Plasmodium falciparum to available non-artemisinin antimalarial drugs, new and novel pharmaceuticals are needed. ARCO® is a new generation ACT, one of several artemisinin-based combinations developed in China...

  • Article
  • Open Access
4 Citations
6,818 Views
11 Pages

Effects of Moxifloxacin on Human Neutrophil and T-Lymphocyte Functions in Vitro

  • Moliehi Potjo,
  • Riana Cockeran,
  • Annette J Theron,
  • Charles Feldman and
  • Ronald Anderson

13 December 2010

Moxifloxacin is useful in the treatment of respiratory infections, including community-acquired pneumonia, and also shows promise in the treatment of tuberculosis, a clinical setting which necessitates extended administration of this agent. Relativel...

  • Review
  • Open Access
29 Citations
12,528 Views
27 Pages

Anticoagulation in the Elderly

  • Helia Robert-Ebadi and
  • Marc Righini

10 December 2010

Management of anticoagulation in elderly patients represents a particularly challenging issue. Indeed, this patient population is at high thromboembolic risk, but also at high hemorrhagic risk. Assessment of the benefit-risk balance of anticoagulatio...

  • Review
  • Open Access
6 Citations
10,422 Views
21 Pages

3 December 2010

Antidepressant therapies, such as selective serotonin reuptake inhibitors (SSRIs), are current first-line treatments for Major Depressive Disorder. However, over 50% of treated patients show an inadequate response to initial antidepressant therapy. I...

  • Review
  • Open Access
15 Citations
12,851 Views
28 Pages

Obesity Drug Update: The Lost Decade?

  • Fayi Yao and
  • Robert George MacKenzie

24 November 2010

The growing worldwide obesity epidemic and obesity-related disorders present a huge unmet medical need for safe and effective anti-obesity medications. The discovery of leptin in 1994 was rapidly succeeded by a wave of related discoveries leading to...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247